Dr. Omid Moshtaghi, MD

Dr. Moshtaghi practices at Sharp Grossmont Outpatient Surgery Center in La Mesa, California.

Dr. Moshtaghi's NPI, 1730675927, was assigned on July 10, 2018. Dr. Moshtaghi graduated from UC Irvine School of Medicine in 2018. Dr. Moshtaghi's California license number on file is A163768.

Dr. Moshtaghi's primary practice is Sharp Grossmont Outpatient Surgery Center, at 5565 Grossmont Center Dr, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 462-8620.

Dr. Moshtaghi's primary practice is Sharp Grossmont Outpatient Surgery Center in La Mesa, California. Dr. Moshtaghi is also affiliated with Sharp Grossmont Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Moshtaghi to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moshtaghi practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Moshtaghi's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Moshtaghi has a license on file in California.

Dmand AI lists chronic nasal allergies, ear eustachian tube disorders, hearing loss and impairment, swimmer's ear and tinnitus among the conditions Dr. Moshtaghi treats.

CMS data shows 6,509 Medicare services from Dr. Moshtaghi across 18 procedure codes in 2024, for 514 Medicare patients. Medicare paid $284,195 for them. Every service was in an office.

CMS counts 514 Medicare patients who saw Dr. Moshtaghi in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moshtaghi's median patient age at 63, with 57% women.

In 2024, Dr. Moshtaghi wrote 1,627 Medicare Part D claims for 503 patients. 92% of them were for generic drugs. CMS names the drug for 1,529 of them, across 17 drugs with 11 or more claims each, at $29,892 in total drug cost. In 2023, CMS named 312 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Moshtaghi for performance year 2024, reported as part of a group. Dr. Moshtaghi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moshtaghi as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 48 papers to Dr. Moshtaghi, published from 2015 to 2025. 2017 was the busiest year, with 14. The most frequent topics are Neuroma, Acoustic, California and Postoperative Complications. Dr. Moshtaghi has published most often in Otol Neurotol. Dr. Moshtaghi's most frequent co-authors are Hamid Reza Djalilian, MD, Harrison William Lin, MD and Ronald Sahyouni, MD, PhD.

CMS Open Payments shows 103 general payments to Dr. Moshtaghi from 23 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 80% of the total. Stryker Corporation paid the most, $1,800.

Dr. Moshtaghi graduated from UC Irvine School of Medicine in 2018.

Dr. Moshtaghi is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.